Related Experiment Video
Updated: Jun 18, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm
Anju Bhardwaj1, James L Januzzi
1Cardiology Division, Massachusetts General Hospital, 32 Fruit Street, Boston, MA 02114, USA.
Abstract:
Natriuretic peptides (B-type natriuretic peptide [BNP] and N-terminal pro-B-type natriuretic peptide [NT]-proBNP) have been proven to be strong diagnostic and prognostic tools in the assessment of acutely decompensated heart failure. The emergence of BNP/NT-proBNP testing as a standard of care in this setting has helped to reduce healthcare costs, and may decrease adverse clinical outcomes. The use of BNP and NT-proBNP to "guide" treatment of acutely destabilized heart failure has recently grown. We present an overview of the value of BNP/NT-proBNP in the context of acute heart failure management and therapy optimization, and present an algorithm for natriuretic peptide-guided treatment of acutely destabilized heart failure.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Acute Kidney Injury VI: Nursing Management
Mitral Regurgitation IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care